These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9094684

  • 1. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus.
    Luo G, Torri A, Harte WE, Danetz S, Cianci C, Tiley L, Day S, Mullaney D, Yu KL, Ouellet C, Dextraze P, Meanwell N, Colonno R, Krystal M.
    J Virol; 1997 May; 71(5):4062-70. PubMed ID: 9094684
    [Abstract] [Full Text] [Related]

  • 2. Identification of a novel HA conformational change inhibitor of human influenza virus.
    Yoshimoto J, Kakui M, Iwasaki H, Fujiwara T, Sugimoto H, Hattori N.
    Arch Virol; 1999 May; 144(5):865-78. PubMed ID: 10416371
    [Abstract] [Full Text] [Related]

  • 3. Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.
    Basu A, Komazin-Meredith G, McCarthy C, Antanasijevic A, Cardinale SC, Mishra RK, Barnard DL, Caffrey M, Rong L, Bowlin TL.
    ACS Infect Dis; 2017 May 12; 3(5):330-335. PubMed ID: 28301927
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a hemagglutinin-specific inhibitor of influenza A virus.
    Luo G, Colonno R, Krystal M.
    Virology; 1996 Dec 01; 226(1):66-76. PubMed ID: 8941323
    [Abstract] [Full Text] [Related]

  • 5. pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.
    Cianci C, Yu KL, Dischino DD, Harte W, Deshpande M, Luo G, Colonno RJ, Meanwell NA, Krystal M.
    J Virol; 1999 Mar 01; 73(3):1785-94. PubMed ID: 9971755
    [Abstract] [Full Text] [Related]

  • 6. Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin.
    Yoshimoto J, Kakui M, Iwasaki H, Sugimoto H, Fujiwara T, Hattori N.
    Microbiol Immunol; 2000 Mar 01; 44(8):677-85. PubMed ID: 11021398
    [Abstract] [Full Text] [Related]

  • 7. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.
    Hoffman LR, Kuntz ID, White JM.
    J Virol; 1997 Nov 01; 71(11):8808-20. PubMed ID: 9343241
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA.
    Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235
    [Abstract] [Full Text] [Related]

  • 9. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin.
    Zhou Y, Wu C, Zhao L, Huang N.
    Proteins; 2014 Oct 01; 82(10):2412-28. PubMed ID: 24854389
    [Abstract] [Full Text] [Related]

  • 10. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion.
    Leikina E, LeDuc DL, Macosko JC, Epand R, Epand R, Shin YK, Chernomordik LV.
    Biochemistry; 2001 Jul 27; 40(28):8378-86. PubMed ID: 11444985
    [Abstract] [Full Text] [Related]

  • 11. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Skehel JJ, Wiley DC.
    Annu Rev Biochem; 2000 Jul 27; 69():531-69. PubMed ID: 10966468
    [Abstract] [Full Text] [Related]

  • 12. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M, Li ZN, Yao Q, Yang C, Steinhauer DA, Compans RW.
    J Virol; 2006 Jun 27; 80(12):6106-14. PubMed ID: 16731949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W, DeFeo CJ, Alvarado-Facundo E, Vassell R, Weiss CD.
    J Virol; 2015 Oct 27; 89(20):10602-11. PubMed ID: 26269180
    [Abstract] [Full Text] [Related]

  • 16. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
    Brancato V, Peduto A, Wharton S, Martin S, More V, Di Mola A, Massa A, Perfetto B, Donnarumma G, Schiraldi C, Tufano MA, de Rosa M, Filosa R, Hay A.
    Antiviral Res; 2013 Aug 27; 99(2):125-35. PubMed ID: 23707194
    [Abstract] [Full Text] [Related]

  • 17. Receptor binding and pH stability - how influenza A virus hemagglutinin affects host-specific virus infection.
    Mair CM, Ludwig K, Herrmann A, Sieben C.
    Biochim Biophys Acta; 2014 Apr 27; 1838(4):1153-68. PubMed ID: 24161712
    [Abstract] [Full Text] [Related]

  • 18. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E, Wharton SA, Mucha V, Gocník M, Kostolanský F.
    Acta Virol; 2003 Apr 27; 47(4):229-36. PubMed ID: 15068378
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.
    Plotch SJ, O'Hara B, Morin J, Palant O, LaRocque J, Bloom JD, Lang SA, DiGrandi MJ, Bradley M, Nilakantan R, Gluzman Y.
    J Virol; 1999 Jan 27; 73(1):140-51. PubMed ID: 9847316
    [Abstract] [Full Text] [Related]

  • 20. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.
    Galloway SE, Reed ML, Russell CJ, Steinhauer DA.
    PLoS Pathog; 2013 Feb 27; 9(2):e1003151. PubMed ID: 23459660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.